Myomo Certified as Medicare Provider – Authorization by Centers for Medicare & Medicaid Services Is One More Important Step

CAMBRIDGE, Mass. (September 15, 2020) – Myomo, Inc. (NYSE American: MYO) (“Myomo” or the “Company”), a wearable medical robotics company that offers increased functionality for those suffering from neurological disorders and upper-limb paralysis, today announced that the Centers for Medicare & Medicaid Services under the U.S. Department of Health and Human Services has authorized the Company to be a Medicare Provider.  Myomo is now included in the Medicare Supplier Directory at Medicare.gov, and this designation enables Myomo to bill Medicare directly when it delivers its MyoPro powered orthosis in 39 states plus D.C.  The Company is working to complete the requirements in the remaining states. Read more.